Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum
| dc.contributor.author | Noureddin, Mazen | |
| dc.contributor.author | Chan, Jean L. | |
| dc.contributor.author | Barradas, Katherine | |
| dc.contributor.author | Dimick-Santos, Lara | |
| dc.contributor.author | Schabel, Elmer | |
| dc.contributor.author | Omokaro, Stephanie O. | |
| dc.contributor.author | Anania, Frank A. | |
| dc.contributor.author | Myers, Robert P. | |
| dc.contributor.author | Miller, Veronica | |
| dc.contributor.author | Sanyal, Arun J. | |
| dc.contributor.author | Chalasani, Naga | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2020-06-25T20:45:47Z | |
| dc.date.available | 2020-06-25T20:45:47Z | |
| dc.date.issued | 2020 | |
| dc.eprint.version | Author's manuscript | en_US |
| dc.identifier.citation | Noureddin, M., Chan, J. L., Barradas, K., Dimick-Santos, L., Schabel, E., Omokaro, S. O., Anania, F. A., Myers, R. P., Miller, V., Sanyal, A. J., & Chalasani, N. (2020). Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.04.039 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/23103 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1053/j.gastro.2020.04.039 | en_US |
| dc.relation.journal | Gastroenterology | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | Author | en_US |
| dc.subject | nonalcoholic fatty liver disease | en_US |
| dc.subject | NASH cirrhosis | en_US |
| dc.subject | nonalcoholic steatohepatitis | en_US |
| dc.title | Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum | en_US |
| dc.type | Article | en_US |